CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

The Government plans to introduce a health food standard for supermarkets to make the average shopping basket 'slightly ...

Research led by the Department of General and Visceral Surgery, Faculty of Medicine, University of Freiburg, Germany has ...

Heart disease was once considered a concern mainly for older adults, but that’s no longer the case. Across India, more young ...

From 1 July, the weight-loss drug Wegovy will become available from Belgian pharmacists on prescription. This means Wegovy is ...

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

Despite a boom in life changing medication like Mounjaro, obesity in the UK is yet to be fully tackled.The weight loss ...

The projections come as National Cancer Institute data notes an increase in uterine cancer cases and deaths over the past 30 ...

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

Large restaurant and fast food chains will soon be required to tell the Government how many calories their customers consume on average as part of a broader plan to improve the nation’s health.

MET-097 is a glucagon-like peptide 1 receptor (GLP-1R) agonist developed at Metsera for treating overweight and obesity and is currently in phase II clinical trials.

Scientists from Western University have discovered that a natural compound found in sweet oranges and tangerines, called ...